These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 29545449

  • 1. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    Liozon E, de Boysson H, Dalmay F, Gondran G, Bezanahary H, Fauchais AL, Ly KH.
    J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica.
    Narváez J, Estrada P, López-Vives L, Ricse M, Zacarías A, Heredia S, Gómez-Vaquero C, Nolla JM.
    Semin Arthritis Rheum; 2015 Dec; 45(3):328-33. PubMed ID: 26186807
    [Abstract] [Full Text] [Related]

  • 3. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
    Barde F, Ascione S, Pacoureau L, Macdonald C, Salliot C, Boutron-Ruault MC, Seror R, Nguyen Y.
    Semin Arthritis Rheum; 2024 Feb; 64():152298. PubMed ID: 38000317
    [Abstract] [Full Text] [Related]

  • 4. Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients.
    Hernández-Rodríguez J, Font C, García-Martínez A, Espígol-Frigolé G, Sanmartí R, Cañete JD, Grau JM, Cid MC.
    Medicine (Baltimore); 2007 Jul; 86(4):233-241. PubMed ID: 17632265
    [Abstract] [Full Text] [Related]

  • 5. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.
    Martínez-Taboda VM, Bartolome MJ, Lopez-Hoyos M, Blanco R, Mata C, Calvo J, Corrales A, Rodriguez-Valverde V.
    Semin Arthritis Rheum; 2004 Aug; 34(1):454-64. PubMed ID: 15305244
    [Abstract] [Full Text] [Related]

  • 6. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
    Paskins Z, Whittle R, Sultan AA, Muller S, Blagojevic-Bucknall M, Helliwell T, Hider S, Roddy E, Mallen C.
    BMC Med; 2018 Jan 10; 16(1):4. PubMed ID: 29316928
    [Abstract] [Full Text] [Related]

  • 7. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
    Pamuk ON, Dönmez S, Karahan B, Pamuk GE, Cakir N.
    Clin Exp Rheumatol; 2009 Jan 10; 27(5):830-3. PubMed ID: 19917168
    [Abstract] [Full Text] [Related]

  • 8. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
    Vieira M, Comarmond C, Labreuche J, Mirouse A, Saadoun D, Richez C, Flipo RM, Hachulla E, Drumez E, Cacoub P, FAIR/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors.
    J Autoimmun; 2022 Oct 10; 132():102868. PubMed ID: 35926375
    [Abstract] [Full Text] [Related]

  • 9. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study.
    Kobayashi D, Suyama Y, Osugi Y, Arioka H, Takahashi O, Kuriyama N.
    Int J Rheum Dis; 2018 Jun 10; 21(6):1314-1321. PubMed ID: 29879315
    [Abstract] [Full Text] [Related]

  • 10. Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study.
    Moreel L, Betrains A, Boeckxstaens L, Molenberghs G, Van Laere K, De Langhe E, Vanderschueren S, Blockmans D.
    Semin Arthritis Rheum; 2024 Oct 10; 68():152499. PubMed ID: 38968729
    [Abstract] [Full Text] [Related]

  • 11. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
    Singh JA, Cleveland JD.
    Clin Rheumatol; 2020 Nov 10; 39(11):3427-3438. PubMed ID: 32399772
    [Abstract] [Full Text] [Related]

  • 12. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy.
    Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C, Capozzoli N, Baricchi R, Boiardi L, Chiaravalloti F.
    Arthritis Rheum; 1991 Mar 10; 34(3):351-6. PubMed ID: 2003856
    [Abstract] [Full Text] [Related]

  • 13. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA, García-Porrúa C, Vázquez-Caruncho M.
    J Rheumatol; 1998 Sep 10; 25(9):1750-5. PubMed ID: 9733456
    [Abstract] [Full Text] [Related]

  • 14. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
    De Miguel E, Karalilova R, Macchioni P, Ponte C, Conticini E, Cowley S, Tomelleri A, Monti S, Monjo I, Batalov Z, Klinowski G, Falsetti P, Kane DJ, Campochiaro C, Hočevar A.
    Ann Rheum Dis; 2024 Feb 15; 83(3):335-341. PubMed ID: 37932008
    [Abstract] [Full Text] [Related]

  • 15. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.
    Rheumatol Int; 2018 Apr 15; 38(4):569-577. PubMed ID: 29124397
    [Abstract] [Full Text] [Related]

  • 16. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
    Chakravarty K, Pountain G, Merry P, Byron M, Hazleman B, Scott DG.
    J Rheumatol; 1995 Sep 15; 22(9):1694-7. PubMed ID: 8523347
    [Abstract] [Full Text] [Related]

  • 17. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
    Esen I, Arends S, Dalsgaard Nielsen B, Therkildsen P, Hansen I, van 't Ende A, Heeringa P, Boots A, Hauge E, Brouwer E, van Sleen Y.
    RMD Open; 2023 Jan 15; 9(1):. PubMed ID: 36631159
    [Abstract] [Full Text] [Related]

  • 18. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
    Crowson CS, Matteson EL.
    Semin Arthritis Rheum; 2017 Oct 15; 47(2):253-256. PubMed ID: 28551169
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular risk factors associated with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Study.
    Yates M, Luben R, Hayat S, Mackie SL, Watts RA, Khaw KT, Wareham NJ, MacGregor AJ.
    Rheumatology (Oxford); 2020 Feb 01; 59(2):319-323. PubMed ID: 31325308
    [Abstract] [Full Text] [Related]

  • 20. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F, Dejaco C, Matteson EL, Dasgupta B.
    JAMA; 2016 Jun 14; 315(22):2442-58. PubMed ID: 27299619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.